Chemotherapy Drugs and their Adjuncts
J5 · Effective Sep 16, 2017
43 active Medicare policies list D59.12, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D59.12 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
| Policy | Effective | Status of D59.12 |
|---|---|---|
| Flow Cytometry | Sep 15, 2026 | Covered |
| Policy | Effective | Status of D59.12 |
|---|---|---|
| Enjaymo (Sutimlimab-Jome) | Apr 1, 2026 | Covered |
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Nov 1, 2020
JE · Effective Dec 6, 2020
JF · Effective Dec 6, 2020
JJ · Effective Oct 25, 2020
JM · Effective Oct 25, 2020
J5 · Effective Oct 25, 2020
J8 · Effective Oct 25, 2020
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J15 · Effective Aug 8, 2021
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Nov 27, 2025
National · Effective Mar 5, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Jun 18, 2026
National · Effective Jul 1, 2026
J5 · Effective Oct 1, 2024
National · Effective Jan 22, 2026
National · Effective Oct 1, 2024
National · Effective Oct 1, 2024
J6 · Effective Jul 1, 2026
National · Effective Sep 3, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2025